Clinical Diagnosis Application of Metagenomic Next-Generation Sequencing of Plasma in Suspected Sepsis
Lisha Wang,Shixiao Li,Jiajia Qin,Tianbin Tang,Jiawen Hong,Tao-Hsin Tung,Chunyan Xu,Sufei Yu,Jiao Qian
DOI: https://doi.org/10.2147/IDR.S395700
2023-02-16
Infection and Drug Resistance
Abstract:Lisha Wang, 1 Shixiao Li, 1 Jiajia Qin, 1 Tianbin Tang, 1 Jiawen Hong, 1 Tao-Hsin Tung, 2 Chunyan Xu, 1 Sufei Yu, 1 Jiao Qian 1 1 Department of Laboratory Medicine, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, People's Republic of China; 2 Evidence-Based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, People's Republic of China Correspondence: Sufei Yu; Jiao Qian, Email ; Purpose: We analyzed the clinical concordance of mNGS test results from blood samples and improved the clinical efficiency of mNGS in the diagnosis of suspected sepsis pathogens. Patients and Methods: In this study, 99 samples of suspected blood flow infection were included for plasma mNGS, and the correlation between mNGS results and blood culture results, serum inflammatory indices, clinical symptoms and antibiotic treatment was analyzed, as well as the comparison with the detection rate of BALF pathogens, as well as the classification of different pathogens in the mNGS results were analyzed. Results: The mNGS pathogen detection rate was higher than that of traditional blood culture (83.02% vs 35.82%). The rate of the mNGS results being consistent with the clinical diagnosis was also higher than that of traditional blood culture (58.49% vs 20.75%). This study shows that bacteria and fungi are the main pathogens in sepsis, and viral sepsis is very rare. In this study, 32% of sepsis patients were secondary to pneumonia. Compared with the pathogen detection rate using alveolar lavage fluid, the detection rate from plasma mNGS was 62.5%. Samples were also easy to sample, noninvasive, and more convenient for clinical application. Conclusion: This study shows that compared with blood culture, the detection rate of mNGS pathogen that meets the diagnosis of sepsis is higher. We need a combination of multiple indicators to monitor the early diagnosis and treatment of sepsis. Keywords: clinical concordance, true positive rate, metagenomic next-generation sequencing, blood infection, sepsis Metagenomic next-generation sequencing (mNGS), a new pathogen detection technology, does not rely on sequence amplification of specific gene primers. It is increasingly used in clinical pathogen detection due to its short sequencing time 1 and high sensitivity, and the approximate detection sensitivity range is 68%-88%. 2,3 We found that the overall pathogen detection sensitivity using mNGS was significantly higher than that of conventional cultures, especially in blood samples. mNGS is also more sensitive in samples containing low levels of nucleic acids from microorganisms and, thus, is less affected by antimicrobial therapy. 4 Additionally, the rate of positive mNGS results may be constant over different time points after sepsis. 5 Severe cases of blood infection will lead to multiple organ failure, neurocognitive impairment, and even death. 6,7 Therefore, rapid diagnosis and preliminary treatment are needed in clinics. Blood culture is the most commonly used method to identify pathogens in sepsis, but it is time-consuming and susceptible to contamination. The positive rate in culture is approximately 30–40%, 8 and the spectrum of disease detection is limited. Therefore, mNGS shows great clinical value for pathogen detection in suspected sepsis. 3 Plasma mNGS detects circulating free DNA (cfDNA), a small nucleic acid fragment filtered into the blood or sterile body fluid after microbial death and lysis. 9 The commercial quantitative plasma mNGS test (ie, the Karius test) was first described in 2019 and used to study and evaluate the true clinical manifestations of the mNGS test in sepsis patients. 3,10 However, there is great controversy in the clinical interpretation of mNGS tests, such as the judgment of low sequence number viruses and how to evaluate whether there are pathogenic bacteria for the detected suspected environmental or human-colonized microbial flora. 11 Therefore, clarifying the concordance between mNGS and the actual clinical diagnosis can best reflect the clinical value of mNGS technology. In the clinical verification conducted by Timothy and other experts, 350 patients who met the diagnostic criteria of sepsis were tested. The diagnostic sensitivity of blood mNGS was 93.7%, and the detection consistency was 84.8% compared with the gold standard of microbial diagnosis. 10 In this study, we aimed to analyze the concordance between the results of laboratory plasma mNGS reports and clinical diagnoses, hoping to improve doctors' confidence in the results of -Abstract Truncated-
pharmacology & pharmacy,infectious diseases